Hantz Financial Services, Inc. Gsk PLC Transaction History

Hantz Financial Services, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 06, 2024	BUY	$42.05 - $47.77 $147,679 - $167,768	3,512 Added 4.52%	81,186 $3.53 Million
Q1 2022 Aug 06, 2024	BUY	$40.23 - $47.74 $369,391 - $438,348	9,182 Added 13.41%	77,674 $3.38 Million
Q4 2021 Aug 06, 2024	BUY	$38.88 - $45.31 $298,131 - $347,437	7,668 Added 12.61%	68,492 $3.02 Million
Q3 2021 Aug 06, 2024	BUY	$38.79 - $43.16 $447,752 - $498,195	11,543 Added 23.42%	60,824 $2.32 Million
Q2 2021 Aug 06, 2024	BUY	$36.52 - $41.46 $551,269 - $625,838	15,095 Added 44.16%	49,281 $1.96 Million
Q1 2021 Aug 06, 2024	BUY	$34.27 - $40.01 $1.17 Million - $1.37 Million	34,186 New	34,186 $1.22 Million
Q4 2020 Aug 06, 2024	SELL	$34.07 - $39.94 $234,571 - $274,986	-6,885 Reduced 20.81%	26,205 $964,000
Q3 2020 Aug 06, 2024	SELL	$38.11 - $42.99 $57,279 - $64,613	-1,503 Reduced 4.34%	33,090 $1.25 Million
Q2 2020 Aug 06, 2024	SELL	$37.87 - $43.58 $35,976 - $41,401	-950 Reduced 2.67%	34,593 $1.41 Million
Q1 2020 Aug 06, 2024	BUY	$32.47 - $48.83 $1.15 Million - $1.74 Million	35,543 New	35,543 $1.35 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Hantz Financial Services, Inc. with notifications on news.